New in vitro models: Numerous posters at the ICAAC were devoted to in vitro
models simulating plasma kinetics, including many concerning new molecules
, especially fluoroquinolones. Gatifloxacine, for example, has been found t
o be very active against Gram positive and intracellular germs.
The performance of clinafloxacine against Gram negatives was also announced
. Moxifloxacine was studied with a novel dynamic in vitro model against pen
icillin-resistant Streptococcus pneumoniae. In this model, the bactericidal
effect was very rapid and complete, with no regrowth.
Advances in the preclinical phase: There was much discussion concerning in
vitro models and experimental infections which are being used to further ac
celerate preclinical investigations of new compounds. Presse Med 1998; 27:S
51-4 (C) 1998, Masson, Paris.